Skip to main content
. Author manuscript; available in PMC: 2023 Jul 25.
Published in final edited form as: Nat Biomed Eng. 2022 Aug 11;6(8):944–956. doi: 10.1038/s41551-022-00917-y

Fig. 5 |. Validation of DISCoVER on patient samples.

Fig. 5 |

a, Schematic of rLAMP multiplexing with SARS-CoV-2 (N gene) and human internal control (RNase P) primer sets. b, DISCoVER signal of SARS-CoV-2-positive saliva samples after multiplexed rLAMP. Values are mean ± s.d. with n = 3 technical replicates. c, Fold change in DISCoVER signal relative to NTC on 30 negative clinical nasal samples at 5 min of Cas13 detection. d, Fold change in DISCoVER signal relative to NTC on 33 positive clinical nasal samples at 5 min of Cas13 detection.